|
HMBOX1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.67729999999544E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.229900E-02 |
| Normal-vs-Stage2 |
2.817600E-02 |
| Normal-vs-Stage3 |
4.74779993098196E-10 |
| Normal-vs-Stage4 |
1.60569999518856E-08 |
| Stage1-vs-Stage2 |
3.220600E-01 |
| Stage1-vs-Stage3 |
8.47950000215647E-08 |
| Stage1-vs-Stage4 |
1.67870000000736E-06 |
| Stage2-vs-Stage3 |
1.921590E-02 |
| Stage2-vs-Stage4 |
1.504100E-02 |
| Stage3-vs-Stage4 |
8.409400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.040520E-04 |
| Normal-vs-AfricanAmerican |
2.833200E-04 |
| Normal-vs-Asian |
7.413400E-01 |
| Caucasian-vs-AfricanAmerican |
2.995200E-01 |
| Caucasian-vs-Asian |
5.021200E-01 |
| AfricanAmerican-vs-Asian |
2.789200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.68230000000747E-05 |
| Normal-vs-Female |
2.337800E-03 |
| Male-vs-Female |
3.208000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.615700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.866200E-02 |
| Normal-vs-Age(61-80Yrs) |
8.305099999939E-07 |
| Normal-vs-Age(81-100Yrs) |
3.417500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.778600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.518000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.959800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.956970E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.113800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.553800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.849000E-01 |
| Normal-vs-Grade 2 |
5.784400E-02 |
| Normal-vs-Grade 3 |
6.80410000009068E-07 |
| Normal-vs-Grade 4 |
3.83099996170699E-10 |
| Grade 1-vs-Grade 2 |
1.175660E-02 |
| Grade 1-vs-Grade 3 |
1.700070E-02 |
| Grade 1-vs-Grade 4 |
5.015800E-03 |
| Grade 2-vs-Grade 3 |
4.966200E-04 |
| Grade 2-vs-Grade 4 |
2.76379999997189E-07 |
| Grade 3-vs-Grade 4 |
1.738040E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.078000E-01 |
| Normal-vs-ccB subtype |
1.59028999999755E-05 |
| ccA subtype-vs-ccB subtype |
1.201120E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.401750E-04 |
| Normal-vs-N1 |
2.597200E-04 |
| N0-vs-N1 |
1.317370E-01 |
|
|
